title: How to handle an industry in disruption: Intervene or laissez-faire?
abstract: An analysis of four regions in four countries suggests that the best way to mitigate disruption of the pharmaceutical industry is not to ignore or stem it but to sponsor initiatives that keep scientists engaged.
authors.affiliation: FasterCures, Milken Institute, Washington, DC 20005, USA. InnoThink Center for Research in Biomedical Innovation, Indianapolis, IN 46228, USA.
authors.forename: Bernard
authors.initials: B
authors.lastname: Munos
mesh_terms: D004059:Diffusion of Innovation; D004345:Drug Industry / Q000639:trends*; D004739:England; D006291:Health Policy; D006801:Humans; D007857:Leadership; D017146:Models, Organizational; D009515:New Jersey; D011792:Quebec; D013557:Switzerland; D014481:United States